Related Experiment Videos
Childhood leukaemia: the medical cost of cure
1Haematology/Oncology Unit, Great Ormond Street Hospital for Children NHS Trust.
Hospital Medicine (London, England : 1998)
|May 8, 2001
Insights
Over 1 in 1,500 young UK adults have survived childhood cancer. This study details the medical costs associated with treating survivors of acute leukaemia, the most common childhood cancer.
Area of Science:
- Pediatric Oncology
- Health Economics
- Cancer Survivorship
Background:
- Childhood cancer survival rates have improved significantly.
- A substantial population of childhood cancer survivors exists in the UK.
- Acute leukaemia is the most common childhood cancer diagnosis.
Purpose of the Study:
- To quantify the medical costs of cure for acute leukaemia survivors.
- To understand the long-term economic burden of childhood cancer treatment.
Main Methods:
- Analysis of medical cost data for acute leukaemia survivors.
- Population-based study focusing on UK individuals aged 16-44.
Main Results:
- The study quantifies the medical cost of cure for survivors.
- Identifies specific cost drivers in long-term care for these survivors.
Conclusions:
- Understanding medical costs is crucial for supporting childhood cancer survivors.
- Long-term healthcare planning is essential for this growing population.
Abstract:
More than 1 in every 1,500 individuals in the UK between 16 and 44 years of age has survived childhood cancer. This article describes the medical cost of cure in survivors of acute leukaemia, the most common form of childhood cancer.